ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC17373-5mg |
|
857066-90-1 |
TMC353121
|
0 | C32H42N6O3 | |
GC17371-10mM (in 1mL DMSO) |
|
1042672-97-8 |
IRAK inhibitor 6
|
0 | C20H20N4O3S | |
GC17371-50mg |
|
1042672-97-8 |
IRAK inhibitor 6
|
0 | C20H20N4O3S | |
GC17371-10mg |
|
1042672-97-8 |
IRAK inhibitor 6
|
0 | C20H20N4O3S | |
GC17371-5mg |
|
1042672-97-8 |
IRAK inhibitor 6
|
0 | C20H20N4O3S | |
GC17370-50mg |
|
144-74-1 |
Sulfathiazole sodium
|
0 | C9H8N3NaO2S2 | |
GC17369-10mM (in 1mL DMSO) |
|
284461-73-0 |
Sorafenib
|
0 | C21H16ClF3N4O3 | |
GC17369-200mg |
|
284461-73-0 |
Sorafenib
|
0 | C21H16ClF3N4O3 | |
GC17369-50mg |
|
284461-73-0 |
Sorafenib
|
0 | C21H16ClF3N4O3 | |
GC17369-20mg |
|
284461-73-0 |
Sorafenib
|
0 | C21H16ClF3N4O3 | |
GC17368-1mg |
|
729589-58-6 |
2-Furoyl-LIGRLO-amide
|
0 | C36H63N11O8 | |
GC17367-10mM (in 1mL DMSO) |
|
90098-04-7 |
Rebamipide
|
0 | C19H15ClN2O4 | |
GC17367-50mg |
|
90098-04-7 |
Rebamipide
|
0 | C19H15ClN2O4 | |
GC17365-10mM (in 1mL DMSO) |
|
1449685-96-4 |
DDR1-IN-1
|
0 | C30H31F3N4O3 | |
GC17365-100mg |
|
1449685-96-4 |
DDR1-IN-1
|
0 | C30H31F3N4O3 | |
GC17365-50mg |
|
1449685-96-4 |
DDR1-IN-1
|
0 | C30H31F3N4O3 | |
GC17365-10mg |
|
1449685-96-4 |
DDR1-IN-1
|
0 | C30H31F3N4O3 | |
GC17365-5mg |
|
1449685-96-4 |
DDR1-IN-1
|
0 | C30H31F3N4O3 | |
GC17364-25mg |
|
— |
Coumarin Thioester
|
0 | C23H24N2O4S | |
GC17364-5mg |
|
— |
Coumarin Thioester
|
0 | C23H24N2O4S | |